SLC16A1 and neoplasm: Because the efficacy of the MCT4 inhibitor AZ93 to block the growth of various cancer cell lines was dependent of MCT1 inhibition [8], it is likely that only concurrent inhibition of MCT1 and MCT4 can impair tumor growth, especially under hypoxic conditions.